Simplex Trading
MRVI icon

Simplex Trading’s Maravai LifeSciences MRVI Stock Holding History

Simplex Trading’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,764
Closed -$127K – 9433
2024
Q1 		$128K Sell
14,764
-31,851
-68% -$215K ﹤0.01% 5328
2023
Q4 		$305K Buy
46,615
+34,845
+296% +$225K ﹤0.01% 4207
2023
Q3 		$117K Sell
11,770
-138,580
-92% -$1.52M ﹤0.01% 4933
2023
Q2 		$1.87M Buy
150,350
+149,533
+18,303% +$2.02M ﹤0.01% 2022
2023
Q1 		$11K Buy
817
+792
+3,168% +$11.4K ﹤0.01% 7469
2022
Q4 		$0 Sell
25
-15,373
-100% -$242K ﹤0.01% 9943
2022
Q3 		$393K Buy
15,398
+10,848
+238% +$272K ﹤0.01% 3750
2022
Q2 		$129K Buy
4,550
+4,193
+1,175% +$133K ﹤0.01% 5211
2022
Q1 		$12K Buy
+357
New +$12K ﹤0.01% 8736
2021
Q4 		– Sell
-2,171
Closed -$87.9K – 11058
2021
Q3 		$86K Buy
2,171
+200
+10% +$9.76K ﹤0.01% 6833
2021
Q2 		$82K Sell
1,971
-32
-2% -$1.24K ﹤0.01% 7016
2021
Q1 		$71K Buy
+2,003
New +$66.4K ﹤0.01% 6190

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's MRVI Position: Q2 2024 in Review

Simplex Trading sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 14,764 shares — an estimated $127K sold.

Simplex Trading first reported a position in MRVI in Q1 2021 and held it in 12 quarters. The position peaked at $1.87M in Q2 2023. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

  • Simplex Trading reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 14,764 Maravai LifeSciences shares in Q2 2024, an estimated $127K.
  • Simplex Trading first reported a position in Maravai LifeSciences in Q1 2021 and held it in 12 quarters.
  • Simplex Trading's Maravai LifeSciences position peaked at $1.87M in Q2 2023.
  • 206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.